Ignite Creation Date:
2024-05-06 @ 1:51 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04144517
Status:
COMPLETED
Last Update Posted:
2024-01-25
First Post:
2019-10-24
Brief Title:
A Study of ALKS 4230 Nemvaleukin Alfa With Pembrolizumab in Head and Neck Cancer
Sponsor:
Mural Oncology Inc
Organization:
Mural Oncology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-24
First Submit QC Date:
October 28 2019
Study First Post Date:
2019-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-08-09
Disp First Submit QC Date:
August 9 2022
Disp First Post Date:
2022-08-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-01-25
Last Update Post Date Type:
ACTUAL